Automation: Defining the Future of ATMP and Vaccine Manufacturing

Join us for an evening of talks, lively discussion and networking - exploring how automation, digitalisation, and AI can optimise manufacturing processes for ATMPs and vaccines.

On behalf of the Scottish Advanced Therapies and Vaccines Network, IBioIC, and the Cell and Gene Therapy Catapult are delighted to host this opportunity for colleagues from across the sector to come together to explore how automation, digitalisation, digital twining and AI can optimise manufacturing processes.

The evening will include a mixture of educational talks and panel discussion, followed by a networking drinks reception. 

About the Scottish Advanced Therapies and Vaccines Network

Coordinated by the Cell and Gene Therapy Catapult, and supported by Scottish Enterprise, the Network fosters collaboration and supports growth across the advanced therapy and vaccine industries in Scotland and beyond, by facilitating opportunities for academic, NHS, and industry experts to connect, exchange knowledge and tackle challenges together.